| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Hergueta-Redondo, Marta |
| dc.contributor.author | Sánchez-Redondo, Sara |
| dc.contributor.author | Hurtado, Begoña |
| dc.contributor.author | Santos, Vanesa |
| dc.contributor.author | Pérez-Martínez, Manuel |
| dc.contributor.author | Ximénez-Embún, Pilar |
| dc.date.accessioned | 2025-05-07T12:52:21Z |
| dc.date.available | 2025-05-07T12:52:21Z |
| dc.date.issued | 2025-04-02 |
| dc.identifier.citation | Hergueta-Redondo M, Sánchez-Redondo S, Hurtado B, Santos V, Pérez-Martínez M, Ximénez- Embún P, et al. The impact of a high fat diet and platelet activation on pre-metastatic niche formation. Nat Commun. 2025 Apr 2;16:2897. |
| dc.identifier.issn | 2041-1723 |
| dc.identifier.uri | http://hdl.handle.net/11351/13048 |
| dc.description | Dieta rica en grasas; Activación plaquetaria; Nicho premetastásico |
| dc.language.iso | eng |
| dc.publisher | Nature Portfolio |
| dc.relation.ispartofseries | Nature Communications;16 |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Mama - Càncer |
| dc.subject | Metàstasi |
| dc.subject | Greix |
| dc.subject | Malalties d'origen nutricional |
| dc.subject | Hemostàsia |
| dc.subject.mesh | Tumor Microenvironment |
| dc.subject.mesh | Triple Negative Breast Neoplasms |
| dc.subject.mesh | Platelet Activation |
| dc.subject.mesh | Neoplasm Metastasis |
| dc.subject.mesh | Diet, High-Fat |
| dc.subject.mesh | /adverse effects |
| dc.title | The impact of a high fat diet and platelet activation on pre-metastatic niche formation |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1038/s41467-025-57938-9 |
| dc.subject.decs | microambiente tumoral |
| dc.subject.decs | neoplasias de mama triple negativos |
| dc.subject.decs | activación plaquetaria |
| dc.subject.decs | metástasis neoplásica |
| dc.subject.decs | alimentación rica en grasa |
| dc.subject.decs | /efectos adversos |
| dc.relation.publishversion | https://doi.org/10.1038/s41467-025-57938-9 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Hergueta-Redondo M, Sánchez-Redondo S, Santos V] Microenvironment and Metastasis Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain. [Hurtado B] Cancer Cell Cycle Group, Preclinical & Translational Research Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Pérez-Martínez M] Confocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain. [Ximénez-Embún P] Proteomics Unit, Biotechnology Programme, Spanish National Cancer Research Center (CNIO), Madrid, Spain |
| dc.identifier.pmid | 40175356 |
| dc.identifier.wos | 001458236100004 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |